CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 314 enrolled
Drug / intervention
Accelerated intensity modulated radiation therapy (AIMRT)radiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02606708
NCT02606708N/ACompleted

Accelerated Intensity Modulated Radiation Therapy (AIMRT) to the Breast After Segmental Mastectomy: a Pilot Study

NYU Langone Health·interventional·Posted Nov 17, 2015·Updated Aug 14, 2020

In Brief

A clinical study evaluating Accelerated intensity modulated radiation therapy (AIMRT) for Breast Cancer. Completed, enrolled 314 participants across 1 site.

Detailed Summary

The primary purpose of this study is to determine the feasibility and tolerability of a regimen of accelerated (hypofractionated) Intensity Modulated Radiation Therapy (AIMRT) to the whole breast as part of breast preservation. In addition, the investigators want to prospectively collect blood specimens to: assess TGF-β polymorphisms to identify potential carriers at higher risk for post-treatment fibrosis; generate a blood specimen repository for future studies of other relevant polymorphisms. The study investigators also want to prospectively follow each treated woman yearly to assess long-term radiation sequelae of the current regimen by using the LENT/SOMA scores.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 17, 2015
Enrollment StartFeb 20, 2005
Primary CompletionJun 2, 2016
Study CompletionJun 2, 2017
TodayJul 2, 2026
Enrollment to primary: 11.3 yearsPosted 10.6 years ago

Interventions

Accelerated intensity modulated radiation therapy (AIMRT)radiation